{Reference Type}: Journal Article
{Title}: Standardizing the surgical management of benign ovarian tumors in children and adolescents: A best practice Delphi consensus statement.
{Author}: Braungart S;Williams C;Arul SG;Bambang K;Craigie RJ;Cross KM;Dick A;Hammond P;Okoye B;Rogers T;Losty PD;Glaser A;Powis M;
{Journal}: Pediatr Blood Cancer
{Volume}: 69
{Issue}: 4
{Year}: 04 2022
{Factor}: 3.838
{DOI}: 10.1002/pbc.29589
{Abstract}: No widely agreed consensus protocols exist for the management of benign ovarian tumors (BOT) in children. This presents a substantial risk for suboptimal management. We aimed to generate multispecialty consensus guidance to standardize surgical management and provide a clear follow-up protocol for children with BOTs.<BR>Prospective two-round confidential e-Delphi consensus survey distributed among multispecialty expert panel; concluded by two semistructured videoconferences.<BR>Consensus was generated on these core outcome sets: preoperative/intraoperative management; follow-up; adolescent gynecology referral. (1) Children with BOTs should receive the same management as other patients with potentially neoplastic lesions: Preoperative discussion at a pediatric oncology multidisciplinary meeting to risk stratify tumors, and management by health professionals with expertise in ovarian-sparing surgery and laparoscopy. (2) Ovarian-sparing surgery for BOTs should be performed wherever possible to maximize fertility preservation. (3) Ovarian masses detected during emergency laparoscopy/laparotomy should be left in situ wherever feasible and investigated appropriately (imaging/tumor markers) before resection. (4) Follow-up should be undertaken for all patients after BOT resection. Patients should be offered referral to adolescent gynecology to discuss fertility implications.<BR>This best practice Delphi consensus statement emphasizes the importance of managing children with BOTs through a well-defined oncological MDT strategy, in order to optimize risk stratification and allow fertility preservation by ovarian-sparing surgery wherever possible.